Home > Diseases we research > Parkinson’s


Parkinson’s disease is a degenerative condition of the central nervous system, characterised by both motor symptoms and non-motor symptoms.
About Parkinson's

What is Parkinson's?

Parkinson’s disease (PD) is a gradually progressive disorder of the brain that affects movement, causing tremors and stiffness. First described by English physician Dr James Parkinson in 1817, it can also include other symptoms like sleep disruption, loss of smell, speech and swallowing problems, cognitive impairment, depression and anxiety.

Key statistics

  • 80,000
    There are about 80,000 Australians living with Parkinson’s disease
  • < 45yrs
    Parkinson’s disease is usually diagnosed around the age of 65, but one in 10 will be diagnosed before they are 45
  • Risk
    Men are slightly more at risk of developing Parkinson’s than women
  • 15-64yrs
    Nearly 1 in 5 sufferers are aged between 15‐64, having what is known as ‘early‐onset’ Parkinson’s
  • 28 daily
    28 Australians are diagnosed with Parkinson’s every day

Parkinson's research at Garvan

Research into Parkinson’s disease (PD) at Garvan is multifaceted, focusing on early PD and its causes, new neuroprotection therapies to prevent progression, brain regeneration and repair, and of course, prevention. Two groups led by Associate Professor Antony Cooper (Neurogenomics) and Dr Daniel Hesselson (Neuroprotection) conduct innovative research in these areas using unique but complementary approaches.

Support our research


Fundraising can be fun, challenging, and hugely rewarding.


Every gift makes a huge difference to our medical research


Your bequest to Garvan will have a lasting impact on future generations.